Novo Nordisk Aktie
62,68
EUR
-0,68
EUR
-1,07
%
59,97
CHF
-1,41
CHF
-2,30
%
Werbung
Novo Nordisk Aktie Analyse
31.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
27.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
30.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
16.09.16 | Novo Nordisk buy | Citigroup Corp. | |
14.09.16 | Novo Nordisk Outperform | BNP PARIBAS | |
05.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
02.09.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
Werbung
|
|||
22.08.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
09.08.16 | Novo Nordisk buy | Citigroup Corp. | |
09.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.08.16 | Novo Nordisk buy | Citigroup Corp. | |
01.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
27.07.16 | Novo Nordisk buy | Citigroup Corp. | |
25.07.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
13.07.16 | Novo Nordisk overweight | Morgan Stanley | |
13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.06.16 | Novo Nordisk buy | Citigroup Corp. | |
15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
14.06.16 | Novo Nordisk buy | Citigroup Corp. | |
14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.05.16 | Novo Nordisk overweight | Barclays Capital | |
29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.02.16 | Novo Nordisk overweight | Barclays Capital | |
04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.16 | Novo Nordisk buy | Citigroup Corp. |
Werbung
Werbung